Garadacimab regulatory approval imminent.
- Forums
- ASX - By Stock
- CSL
- Garadacimab for HAE long term results “complete disease control”
CSL
csl limited
Add to My Watchlist
3.09%
!
$256.06

Garadacimab for HAE long term results “complete disease control”, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$256.06 |
Change
7.670(3.09%) |
Mkt cap ! $123.6B |
Open | High | Low | Value | Volume |
$252.00 | $256.17 | $251.10 | $223.7M | 868.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 63 | $256.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$256.06 | 37 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 81 | 255.760 |
3 | 17 | 255.750 |
1 | 2 | 255.740 |
3 | 34 | 255.730 |
3 | 62 | 255.720 |
Price($) | Vol. | No. |
---|---|---|
255.800 | 1 | 1 |
255.810 | 14 | 2 |
255.820 | 10 | 1 |
255.840 | 6 | 1 |
255.850 | 1 | 1 |
Last trade - 12.36pm 18/07/2025 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |